20160743

Source:http://linkedlifedata.com/resource/pubmed/id/20160743

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0038137, umls-concept:C0039422, umls-concept:C0175675, umls-concept:C0752189
pubmed:issue	3
pubmed:dateCreated	2010-2-17
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0372741
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Biological Agents, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins
pubmed:status	MEDLINE
pubmed:month	Mar
pubmed:issn	1532-6535
pubmed:author	pubmed-author:HughesD ADA
pubmed:issnType	Electronic
pubmed:volume	87
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	257-61
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:20160743-Animals, pubmed-meshheading:20160743-Biological Agents, pubmed-meshheading:20160743-Biomedical Technology, pubmed-meshheading:20160743-Evidence-Based Medicine, pubmed-meshheading:20160743-Humans, pubmed-meshheading:20160743-Recombinant Proteins, pubmed-meshheading:20160743-Technology Assessment, Biomedical
pubmed:year	2010
pubmed:articleTitle	Biosimilars: evidential standards for health technology assessment.
pubmed:affiliation	Centre for Economics and Policy in Health, Institute of Medical and Social Care Research, Bangor University, Bangor, Wales, UK. d.a.hughes@bangor.ac.uk
pubmed:publicationType	Journal Article, Review